$LHCG (LHC Group, Inc.)

$LHCG {{ '2016-04-13T23:33:18+0000' | timeago}} • Announcement

Lafayette, Louisiana-based $LHCG said that it has named Joshua Proffitt as EVP, CFO and Treasurer, effective April 30, 2016. Proffitt, previously EVP, Corporate Development and General Counsel, will replace current EVP, CFO and Treasurer, Dionne Viator, who will be leaving the Company to pursue other interests.

$HLS {{ '2017-07-20T13:56:35+0000' | timeago}} • Announcement

The BoD of $HLS declared a quarterly cash dividend on its common stock of $0.25 per share. The dividend is payable on Oct. 16, 2017, to stockholders of record on Oct. 2, 2017.

$INCY {{ '2017-07-20T13:24:37+0000' | timeago}} • Announcement

$INCY said first patient has been treated in Phase 3 trial of itacitinib for the first-line treatment of patients with acute graft-versus-host disease (GVHD). GVHD is a condition that might occur after an allogeneic transplant, whereby the donated bone marrow or peripheral blood stem cells view the recipient’s body as foreign and attack the body.

$AGN {{ '2017-07-19T15:54:53+0000' | timeago}} • Announcement

$AGN appointed Joseph Boccuzi to its BoD, effective immediately. Boccuzi recently retired as a Partner in the Global Life Sciences, Board and Chief Executive Officer Practices at Spencer Stuart, following 24 years of service with the global executive search and leadership consulting firm.

$AMGN {{ '2017-07-13T12:24:26+0000' | timeago}} • Announcement

$AMGN and $AGN announced they will discuss data supporting the ABP 215 Biologics License Application (BLA) with FDA's Oncologic Drugs Advisory Committee. ABP 215 is a biosimilar candidate to Avastin (bevacizumab) and is the first bevacizumab biosimilar candidate to be considered by the FDA.

$HLS {{ '2017-07-11T10:50:33+0000' | timeago}} • Announcement

$HLS expects the total rebranding investment to be about $25-30MM, to be incurred between 2017 and 2019. About $7-10MM is expected to be incurred in 2017, of which $6-8MM will be operating expenses and $1-2MM will be capital expenditures. Only $1MM of this investment is included in 2017 forecast which will be updated in 2Q17 results.

$HLS {{ '2017-07-11T10:46:49+0000' | timeago}} • Announcement

$HLS said it will change its name to Encompass Health Corp., effective Jan. 2, 2018. The corporate name change will be accompanied by a NYSE ticker symbol change, from $HLS to "EHC". Beginning in 1Q18, both business segments will begin transitioning to the Encompass Health name.

$AGN {{ '2017-07-10T16:14:16+0000' | timeago}} • Announcement

$AGN announced additional results of a prespecified prospective pooled subgroup analysis from the two Phase 3 studies, which evaluated the efficacy and safety of Viberzi to treat the symptoms associated with irritable bowel syndrome with diarrhea, abdominal pain and diarrhea.

$PRSC {{ '2017-07-07T15:47:58+0000' | timeago}} • Announcement

$PRSC has appointed Jeff Felton as the CEO of its subsidiary LogistiCare Solutions, LLC, effective July 10, 2017. He most recently served as President of McKesson Connected Care and Analytics and he has also worked at Cardinal Health, Baxter Healthcare and Procter and Gamble.

$USPH {{ '2017-06-29T19:00:45+0000' | timeago}} • Webcast

$USPH estimates its corporate office costs, as a percentage of revenue, will be in the upper 8% to lower 9% range this year. The company said its recently adopted accounting standard and a change in the value of restricted share grants resulted in tax credit in 1Q17. The current focus is on acquisition-related opportunities to sustain growth.

$USPH {{ '2017-06-29T18:56:30+0000' | timeago}} • Webcast

$USPH expects its newly-launched analytics tool to bear good fruit as the year progresses. The company intends to continue consolidation of its smaller partnerships. The visits per clinic per day progressed sequentially in 1Q17 and has continued to progress well.

$WBA {{ '2017-06-29T14:01:47+0000' | timeago}} • Announcement

$WBA agreed to buy 2,186 stores, three distribution centers and related inventory from $RAD. $WBA expects the new transaction to be modestly accretive to its adjusted EPS in the first full year after the initial closing of the new transaction, and expects to realize synergies from the new transaction in excess of $400MM.

$WBA {{ '2017-06-29T14:01:00+0000' | timeago}} • Announcement

$WBA agreed to buy 2,186 stores, three distribution centers and related inventory from $RAD. This new agreement replaces the previous merger agreement with Rite Aid, announced in October 2015 and amended in January 2017. The initial closing of the new transaction is expected to occur within the next six months.

$WBA {{ '2017-06-29T14:00:00+0000' | timeago}} • Announcement

$WBA agreed to buy 2,186 stores, three distribution centers and related inventory from $RAD. The consideration for the transaction will be $5.175Bil in cash, the assumption by $WBA of the related real estate leases and the grant of an option to $RAD to become a member of $WBA's group purchasing organization, Walgreens Boots Alliance Development.

$WBA {{ '2017-06-29T13:35:36+0000' | timeago}} • Webcast

$WBA said that on the $RAD agreement, while the company is assuming a real-estate obligation, it is not assuming any debt. Additionally, $WBA is expecting the deal to give significant cash tax benefit, as it tax amortizes the intangible assets it acquires from $RAD.

$USPH {{ '2017-06-29T12:50:35+0000' | timeago}} • Announcement

$USPH's revenue for 1Q17 increased 12.3% from last year. This was primarily due to a 10.1% rise in net patient revenues from physical therapy operations, higher revenues from management contracts due to rise in managed facilities and one month of revenues from workforce performance solutions business acquired in March 2017.

$USPH {{ '2017-06-29T12:48:56+0000' | timeago}} • Announcement

$USPH reported a rise in 1Q17 earnings as a rise in net patient revenues from physical therapy operations and an increase in revenues from management contracts drove revenue higher. Net income rose to $4.82MM or $0.38 per share from $4.49MM or $0.36 per share last year. Revenue grew 12.3% to $97.57MM. Operating EPS increased 8.5% to $0.51.

$RAD {{ '2017-06-29T12:19:47+0000' | timeago}} • Announcement

In 1Q18, $RAD opened one store, relocated four, remodeled 67 and expanded one store, bringing the total number of wellness stores chainwide to 2,482. The company closed 14 stores, resulting in a total store count of 4,523 at the end of the first quarter.

$RAD {{ '2017-06-29T12:18:00+0000' | timeago}} • Announcement

Drugstore chain $RAD posted revenue of $7.8Bil in 1Q18, a decrease of 4.9%, as same store sales slid 3.9% YoY. Net loss widened to $75.3MM or $0.07 per share, compared to last year’s $4.6MM or $0.00 per share, hurt by lower pharmacy gross profit. Adjusted EBITDA was $192.6MM compared to $286MM in the year-over period.

$RAD {{ '2017-06-29T12:09:28+0000' | timeago}} • Announcement

$RAD and $WBA announced that the latter will not buy the former as initially announced. Instead of the previously announced deal that was severely scrutinized by the Federal Trade Commission, $WBA will instead buy 2,186 Rite Aid Stores and Related Assets for $5.17Bil. Rite Aid will receive $325MM from $WBA as termination fee.

$WBA {{ '2017-06-29T11:32:22+0000' | timeago}} • Announcement

$WBA, which reached an agreement with $RAD worth $5.17Bil today, reported a modest 5% increase in earnings for 3Q17 upon strategic partnerships that brought more patients to its pharmacies. Both sales and earnings inched up, with sales scaling up 2.1% to $30.1Bil, while earnings rose to $1,162MM. Adjusted earnings spiked 12.7% to $1.33 per share.

Recent Transcripts

USPH (US Physical Therapy Inc.)
Thursday, June 29 2017 - 2:30pm
MCK (McKesson Corporation)
Thursday, May 18 2017 - 9:00pm
PTX (Pernix Therapeutics Holdings, Inc.)
Monday, May 15 2017 - 8:30pm
PMC (PharMerica Corporation)
Wednesday, May 10 2017 - 2:00pm
PRSC (Providence Service Corp.)
Wednesday, May 10 2017 - 12:00pm
ACAD (ACADIA Pharmaceuticals Inc.)
Tuesday, May 9 2017 - 9:00pm
ATRS (Antares Pharma Inc.)
Tuesday, May 9 2017 - 12:30pm
AGN (Allergan plc)
Tuesday, May 9 2017 - 12:30pm
PETS (PetMed Express, Inc.)
Monday, May 8 2017 - 12:30pm
OFIX (Orthofix International N.V.)
Thursday, May 4 2017 - 8:30pm
LHCG (LHC Group, Inc.)
Thursday, May 4 2017 - 3:00pm
MD (MEDNAX, Inc.)
Thursday, May 4 2017 - 2:00pm
INCY (Incyte Corporation)
Thursday, May 4 2017 - 2:00pm
KND (Kindred Healthcare Inc.)
Thursday, May 4 2017 - 1:00pm
AMRN (Amarin Corporation plc)
Wednesday, May 3 2017 - 12:00pm
CVS (CVS Health Corporation)
Tuesday, May 2 2017 - 12:30pm
HLS (HEALTHSOUTH Corp.)
Friday, April 28 2017 - 1:00pm
TVTY (Tivity Health, Inc.)
Thursday, April 27 2017 - 9:00pm
CHE (Chemed Corp.)
Thursday, April 27 2017 - 2:00pm
IART (Integra LifeSciences Holdings Corporation)
Wednesday, April 26 2017 - 12:30pm

AlphaGraphics you may like